| [1] |
Faggiano A, Milone F, Ramundo V, et al. A decrease of calcitonin serum concentations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal[J]. J Clin Endocrinol Metab, 2010, 95(9):E32-E36.DOI:10.1210/jc.2010-0045. |
| [2] |
董薇, 陈晓红.甲状腺髓样癌研究进展[J].国际耳鼻咽喉头颈外科杂志, 2013, 37(1):42-46. DOI:10.3760/cma.j.issn.1673-4106. 2013.01.011. Dong W, Chen XH. Advances in medullary thyroid carcinoma[J]. Int J Otolaryngol Head Neck Surg, 2013, 37(1):42-46. doi: 10.3760/cma.j.issn.1673-4106.2013.01.011 |
| [3] |
Mukherjee SP, Lyng FM, Garcia A, et al. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells[J]. Toxicol Appl Pharmacol, 2010, 248(3):259-268. DOI:10. 1016/j.taap.2010.08.016. |
| [4] |
Kannan S, Kolhe P, Raykova V, et al. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells[J]. J Biomater Sci Polym Ed, 2004, 15(3):311-330. DOI:10.1163/156856204322977201. |
| [5] |
Böckmann M, Hilken G, Schmidt A, et al. Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection[J]. Hum Gene Ther, 2005, 16(11):1267-1275. DOI:10.1089/hum.2005.16.1267. |
| [6] |
Urbiola K, Blanco-Fernández L, Navarro G, et al. Evaluation of improved PAMAM-G5 conjugates for gene delivery targeted to the transferrin receptor[J]. Eur J Pharm Biopharm, 2015, 94:116-122. DOI:10.1016/j.ejpb.2015.05.007. |
| [7] |
刘金剑, 刘鉴峰.纳米材料在核医学中的应用[J].国际放射医学核医学杂志, 2010, 34(6):326-329. DOI:10.3760/cma.j.issn.1673-4114, 2010.06.002. Liu JJ, Liu JF. The applications of nanomaterials in nuclear medicine[J]. Int J Radiat Med Nucl Med, 2010, 34(6):326-329. doi: 10.3760/cma.j.issn.1673-4114,2010.06.002 |
| [8] |
Zeng Y, Kurokawa Y, Win-Shwe TT, et al. Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells[J]. J Toxicol Sci, 2016, 41(3):351-370. DOI:10.2131/jts.41.351. |
| [9] |
He R, Wang HW, Su YL, et al. Incorporating 131I into a PAMAM (G5.0) dendrimer-conjugate:design of a theranostic nanosensor for medullary thyroid carcinama[J]. RSC Adv, 2017, 7:16181-16188. DOI:10.1039/C7RA00604G. |
| [10] |
Wang YA, Shen WW, Shi XY, et al. Alpha-Tocopheryl SuccinateConjugated G5 PAMAM dendrimer enables effective inhibition of ulcerative colitis[J/OL]. Adv Healthc Mater, 2017, 6(14):1700276[2017-08-15]. http://onlinelibrary.wiley.com/doi/10.1002/adhm.201700276/pdf.DOI:10.1002/adhm.201700276. |
| [11] |
Pourianazar NT, Mutlu P, Gunduz U. Bioapplications of poly (amidoamine) (PAMAM) dendrimers in nanomedicine[J/OL]. J Nanopart Res, 2014, 16:2342[2017-08-15]. https://www.researchgate.net/publication/266991692_bioapplications_of_polyamidoamine_pamam_dendrimers_in_nanomedicine.DOI:10.1007/s11051-014-2342-1. |
| [12] |
李承霞, 李玮, 张富海, 等. 131I标记抗表皮生长因子受体抗体靶向性纳米载体治疗胶质母细胞瘤的可行性实验研究[J].中华放射医学与防护杂志, 2016, 36(3):161-167. DOI:10.3760/cma.j.issn. 0254-5098.2016.03.001. Li CX, Li W, Zhang FH, et al. Targeting therapeutic effect of radioiodine-labeled anti-EGFR binding nanoparticles on glioblastoma cells[J]. Chin J Radiol Med Prot, 2016, 36(3):161-167. doi: 10.3760/cma.j.issn.0254-5098.2016.03.001 |